Concepts (89)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Macaca fascicularis | 2 | 2020 | 913 | 0.680 |
Why?
|
| Epitope Mapping | 2 | 2020 | 300 | 0.670 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2020 | 827 | 0.520 |
Why?
|
| Receptors, IgG | 1 | 2018 | 564 | 0.500 |
Why?
|
| Vision Disorders | 1 | 2022 | 1093 | 0.480 |
Why?
|
| Oligopeptides | 1 | 2020 | 1194 | 0.460 |
Why?
|
| Headache | 1 | 2022 | 1262 | 0.460 |
Why?
|
| High-Throughput Screening Assays | 1 | 2020 | 937 | 0.450 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2020 | 1362 | 0.430 |
Why?
|
| Proteomics | 1 | 2022 | 3906 | 0.320 |
Why?
|
| Genotype | 2 | 2024 | 13042 | 0.250 |
Why?
|
| Prothrombin | 1 | 2024 | 193 | 0.220 |
Why?
|
| Factor V | 1 | 2024 | 168 | 0.220 |
Why?
|
| Haplotypes | 2 | 2020 | 2724 | 0.210 |
Why?
|
| Models, Animal | 2 | 2020 | 2124 | 0.210 |
Why?
|
| Macaca mulatta | 2 | 2020 | 2362 | 0.200 |
Why?
|
| Cat Diseases | 1 | 2021 | 32 | 0.190 |
Why?
|
| Enzyme-Linked Immunospot Assay | 1 | 2020 | 126 | 0.170 |
Why?
|
| Glycine | 1 | 2022 | 672 | 0.160 |
Why?
|
| Biological Specimen Banks | 1 | 2024 | 784 | 0.150 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 2018 | 306 | 0.140 |
Why?
|
| Heterozygote | 1 | 2024 | 2791 | 0.140 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2018 | 228 | 0.140 |
Why?
|
| Major Histocompatibility Complex | 1 | 2020 | 877 | 0.140 |
Why?
|
| Biological Evolution | 2 | 2021 | 1078 | 0.130 |
Why?
|
| Antigens, Viral | 1 | 2020 | 992 | 0.130 |
Why?
|
| Gene Library | 1 | 2018 | 1061 | 0.120 |
Why?
|
| Simian immunodeficiency virus | 1 | 2020 | 814 | 0.120 |
Why?
|
| Immunity | 1 | 2018 | 1003 | 0.100 |
Why?
|
| Orthoreovirus, Mammalian | 1 | 2012 | 40 | 0.100 |
Why?
|
| Clathrin-Coated Vesicles | 1 | 2012 | 67 | 0.100 |
Why?
|
| Hydrazones | 1 | 2012 | 105 | 0.100 |
Why?
|
| Gene Frequency | 1 | 2018 | 3617 | 0.100 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2018 | 1360 | 0.090 |
Why?
|
| Virion | 1 | 2012 | 430 | 0.090 |
Why?
|
| Proteome | 1 | 2020 | 1881 | 0.080 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2018 | 3666 | 0.080 |
Why?
|
| Feasibility Studies | 1 | 2020 | 5313 | 0.080 |
Why?
|
| Virus Internalization | 1 | 2012 | 503 | 0.080 |
Why?
|
| Alleles | 1 | 2018 | 6892 | 0.070 |
Why?
|
| Antibodies, Viral | 1 | 2018 | 3211 | 0.070 |
Why?
|
| Immunoglobulin G | 1 | 2018 | 4570 | 0.070 |
Why?
|
| Protein Binding | 1 | 2018 | 9343 | 0.070 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2020 | 4646 | 0.060 |
Why?
|
| Pregnancy Complications | 1 | 2018 | 2972 | 0.060 |
Why?
|
| Animals | 7 | 2021 | 169337 | 0.060 |
Why?
|
| Fibroblasts | 1 | 2012 | 4177 | 0.050 |
Why?
|
| Breeding | 1 | 2020 | 51 | 0.040 |
Why?
|
| Adaptation, Biological | 1 | 2021 | 147 | 0.040 |
Why?
|
| Indonesia | 1 | 2020 | 131 | 0.040 |
Why?
|
| Cats | 1 | 2021 | 978 | 0.040 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2021 | 339 | 0.040 |
Why?
|
| Microsatellite Repeats | 1 | 2020 | 784 | 0.040 |
Why?
|
| Macaca | 1 | 2018 | 417 | 0.040 |
Why?
|
| Seroepidemiologic Studies | 1 | 2018 | 405 | 0.040 |
Why?
|
| Humans | 7 | 2024 | 768393 | 0.030 |
Why?
|
| Cross Reactions | 1 | 2018 | 828 | 0.030 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2021 | 620 | 0.030 |
Why?
|
| Selection, Genetic | 1 | 2021 | 877 | 0.030 |
Why?
|
| Viremia | 1 | 2018 | 725 | 0.030 |
Why?
|
| Antibody Formation | 1 | 2018 | 1393 | 0.030 |
Why?
|
| Phylogeny | 1 | 2021 | 2843 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2021 | 2866 | 0.030 |
Why?
|
| beta-Cyclodextrins | 1 | 2012 | 67 | 0.030 |
Why?
|
| Genistein | 1 | 2012 | 87 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 2021 | 1893 | 0.030 |
Why?
|
| Epitopes | 1 | 2018 | 2525 | 0.020 |
Why?
|
| Dynamins | 1 | 2012 | 141 | 0.020 |
Why?
|
| Adult | 2 | 2024 | 223640 | 0.020 |
Why?
|
| Venous Thromboembolism | 1 | 2024 | 1881 | 0.020 |
Why?
|
| Caveolin 1 | 1 | 2012 | 255 | 0.020 |
Why?
|
| Female | 4 | 2024 | 397089 | 0.020 |
Why?
|
| Thrombosis | 1 | 2024 | 2955 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2012 | 1647 | 0.020 |
Why?
|
| Endocytosis | 1 | 2012 | 959 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2012 | 1974 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2021 | 14737 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2021 | 6606 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2024 | 16028 | 0.010 |
Why?
|
| Cell Survival | 1 | 2012 | 5792 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2024 | 18048 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2012 | 5900 | 0.010 |
Why?
|
| Cell Line | 1 | 2012 | 15597 | 0.010 |
Why?
|
| Male | 3 | 2024 | 364902 | 0.010 |
Why?
|
| Risk Factors | 1 | 2024 | 74962 | 0.010 |
Why?
|
| Pregnancy | 1 | 2018 | 30200 | 0.010 |
Why?
|
| Aged | 1 | 2024 | 171562 | 0.010 |
Why?
|
| Middle Aged | 1 | 2024 | 223491 | 0.010 |
Why?
|
| Mice | 1 | 2012 | 82017 | 0.000 |
Why?
|
Concepts
(89)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(10)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_